(189) developed an open-source software-based analytic pipeline to quantify TILs from whole-slide images of 578 stage III or high-risk stage II CRC patients, which were stained for CD3+ and CD8+ using IHC. The gene discussed is CD8A; the disease is colorectal carcinoma.